Literature DB >> 16014914

Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.

Alexander Bukreyev1, Igor M Belyakov, Gregory A Prince, Kevin C Yim, Katie K Harris, Jay A Berzofsky, Peter L Collins.   

Abstract

The outcome of a viral infection or of immunization with a vaccine can be influenced by the local cytokine environment. In studies of experimental vaccines against respiratory syncytial virus (RSV), an increased stimulation of Th2 (T helper 2) lymphocytes was associated with increased immunopathology upon subsequent RSV infection. For this study, we investigated the effect of increased local expression of the Th2 cytokine interleukin-4 (IL-4) from the genome of a recombinant RSV following primary infection and after a challenge with wild-type (wt) RSV. Mice infected with RSV/IL-4 exhibited an accelerated pulmonary inflammatory response compared to those infected with wt RSV, although the wt RSV group caught up by day 8. In the first few days postinfection, RSV/IL-4 was associated with a small but significant acceleration in the expansion of pulmonary T lymphocytes specific for an RSV CD8(+) cytotoxic T-lymphocyte (CTL) epitope presented as a major histocompatibility complex class I tetramer. However, by day 7 the response of tetramer-positive T lymphocytes in the wt RSV group caught up and exceeded that of the RSV/IL-4 group. At all times, the CTL response of the RSV/IL-4 group was deficient in the production of gamma interferon and was nonfunctional for in vitro cell killing. The accelerated inflammatory response coincided with an accelerated accumulation and activation of pulmonary dendritic cells early in infection, but thereafter the dendritic cells were deficient in the expression of B7-1, which governs the acquisition of cytolytic activity by CTL. Following a challenge with wt RSV, there was an increase in Th2 cytokines in the animals that had previously been infected with RSV/IL-4 compared to those previously infected with wt RSV, but the CD8(+) CTL response and the amount of pulmonary inflammation were not significantly different. Thus, a strong Th2 environment during primary pulmonary immunization with live RSV resulted in early inflammation and a largely nonfunctional primary CTL response but had a minimal effect on the secondary response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014914      PMCID: PMC1181599          DOI: 10.1128/JVI.79.15.9515-9526.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  IL-4 directs the development of Th2-like helper effectors.

Authors:  S L Swain; A D Weinberg; M English; G Huston
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

2.  Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection.

Authors:  J J Anderson; J Norden; D Saunders; G L Toms; R Scott
Journal:  J Gen Virol       Date:  1990-07       Impact factor: 3.891

3.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.

Authors:  F Lee; T Yokota; T Otsuka; P Meyerson; D Villaret; R Coffman; T Mosmann; D Rennick; N Roehm; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity.

Authors:  Y W Tang; B S Graham
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

6.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

7.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.

Authors:  Jun Chang; Thomas J Braciale
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

8.  Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter.

Authors:  Y Noma; P Sideras; T Naito; S Bergstedt-Lindquist; C Azuma; E Severinson; T Tanabe; T Kinashi; F Matsuda; Y Yaoita
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

9.  Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.

Authors:  Y Chiba; Y Higashidate; K Suga; K Honjo; H Tsutsumi; P L Ogra
Journal:  J Med Virol       Date:  1989-07       Impact factor: 2.327

10.  Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.

Authors:  Y Kawakami; S A Rosenberg; M T Lotze
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more
  15 in total

1.  The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response.

Authors:  Alexander Kotelkin; Igor M Belyakov; Lijuan Yang; Jay A Berzofsky; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.

Authors:  James A Harker; Debbie C P Lee; Yuko Yamaguchi; Belinda Wang; Alexander Bukreyev; Peter L Collins; John S Tregoning; Peter J M Openshaw
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

3.  Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.

Authors:  Young-Tae Lee; Ki-Hye Kim; Hye Suk Hwang; Youri Lee; Young-Man Kwon; Eun-Ju Ko; Yu-Jin Jung; Yu-Na Lee; Min-Chul Kim; Sang-Moo Kang
Journal:  Virology       Date:  2015-07-18       Impact factor: 3.616

4.  Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.

Authors:  James A Harker; Alexandra Godlee; Jennifer L Wahlsten; Debbie C P Lee; Lucy G Thorne; Devika Sawant; John S Tregoning; Rachel R Caspi; Alexander Bukreyev; Peter L Collins; Peter J M Openshaw
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

5.  DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.

Authors:  Mathieu Boxus; Marylène Tignon; Stefan Roels; Jean-François Toussaint; Karl Walravens; Marie-Ange Benoit; Philippe Coppe; Jean-Jacques Letesson; Carine Letellier; Pierre Kerkhofs
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  Virally delivered cytokines alter the immune response to future lung infections.

Authors:  James Harker; Alexander Bukreyev; Peter L Collins; Belinda Wang; Peter J M Openshaw; John S Tregoning
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

7.  Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

8.  Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice.

Authors:  Thomas R Jerrells; Jacqueline A Pavlik; Jane DeVasure; Debbie Vidlak; Amy Costello; Jennifer M Strachota; Todd A Wyatt
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

9.  STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection.

Authors:  Martin L Moore; Dawn C Newcomb; Vrajesh V Parekh; Luc Van Kaer; Robert D Collins; Weisong Zhou; Kasia Goleniewska; Michael H Chi; Daphne Mitchell; Joshua A Boyce; Joan E Durbin; Carla Sturkie; R Stokes Peebles
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

10.  The roles of chemokines in rabies virus infection: overexpression may not always be beneficial.

Authors:  Ling Zhao; Harufusa Toriumi; Yi Kuang; Huanchun Chen; Zhen F Fu
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.